Our team aims to further elucidate the heritability of cardiovascular diseases, with a particular emphasis on cardiac arrhythmia and valve disorders.

To examine the contribution of both rare and common genetic variation on disease susceptibility we apply state-of-the art multi-omic approaches.
While our investigations are primarily focused on gene sequences, we now aim to address the role of regulatory regions in the non-coding portion of the genome.

Our goal is to identify biological risk markers for early prevention and new targets for innovative therapies.